| Business Summary | | Inverness
Medical
Technology,
Inc.,
formerly
Selfcare,
Inc.,
develops,
manufactures
and
markets
products
focused
primarily
on
diabetes
self-management.
The
Company's
principal
products
are
advanced
electrochemical
blood
glucose-monitoring
systems
that
are
used
by
people
with
diabetes
to
determine
their
blood
glucose
levels.
Such
systems
utilize
the
Company's
proprietary
biosensor
test
strips,
which
quickly
draw
blood
into
the
strip,
require
a
small
sample
and
provide
users
with
the
option
of
sampling
from
the
forearm,
thus
avoiding
the
need
for
finger
sticking.
The
Company
also
sells
products
for
the
women's
health
market
and,
to
a
lesser
extent,
the
infectious
disease
market.
Products
for
the
women's
health
market
include
home
pregnancy
detection
tests,
ovulation
prediction
tests
and
a
line
of
nutritional
supplements.
Products
for
the
infectious
disease
market
include
tests
used
for
the
detection
of
certain
diseases
and
agents,
such
as
HIV-1
and
HIV-2,
hepatitis
and
chlamydia. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Inverness
Medical
Technology,
Inc.
develops,
manufactures
and
markets
self-test
and
self-care
products
for
the
diabetes,
women's
health
and
infectious
disease
markets.
For
the
six
months
ended
6/30/01,
net
revenues
increased
45%
to
$111.7
million.
Net
loss
before
extraordinary
item
and
applicable
to
Common
totaled
$52.5
million
vs.
an
income
of
$4.6
million.
Revenues
reflect
increased
sales
of
the
blood
glucose
monitoring
system.
Net
loss
reflects
the
charge
for
in-process
R&D. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Ron Zwanziger, 47 Chairman,
Pres and CEO | $350K | $6.8M | John Wilkens, 53 Managing
Director, Iverness Medical Limited | -- | -- | Kenneth Legg, Ph.D., 58 Exec.
VP, Sec. | 203K | -- | Duane James, 41 VP-Fin.,
Treasurer | -- | -- | John Yonkin, 41 VP
of Sales and Marketing,and Gen. Mang.. | -- | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|